OxThera: Pivotal study is being conducted with Oxabact(TM) for the treatment of Primary Hyperoxaluria (Business Wire via Yahoo! Finance)
STOCKHOLM, Sweden—-OxThera today announced that all 42 patients have been enrolled in their pivotal phase II/III study using Oxabactâ„¢ for the treatment of Primary Hyperoxaluria.